⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OLMA News
Olema Pharmaceuticals, Inc. Common Stock
ESR1 Mutated Metastatic Breast Cancer Market Research Report 2026: Epidemiological Analysis, Competitive Landscape, Regulatory Landscape, Pipeline Analysis, M&A, Regulatory Activities, Funding,
globenewswire.com
AZN
OLMA
BIO
ROG
PFE
Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting
globenewswire.com
OLMA
Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting
globenewswire.com
OLMA
Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
globenewswire.com
OLMA
Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
globenewswire.com
OLMA
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
OLMA
Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
globenewswire.com
OLMA
Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
globenewswire.com
OLMA
Form 8-K
sec.gov
OLMA
Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
globenewswire.com
OLMA